Inter Pharma (Thailand) Today
| IP Stock | THB 3.46 0.04 1.17% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Inter Pharma is selling for 3.46 as of the 13th of December 2024. This is a 1.17 percent increase since the beginning of the trading day. The stock's last reported lowest price was 3.36. Inter Pharma has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of November 2023 and ending today, the 13th of December 2024. Click here to learn more.
Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand. The company has 372.52 M outstanding shares. More on Inter Pharma Public
Moving together with Inter Stock
Moving against Inter Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Inter Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Inter Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Inter Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Inter Pharma Public (IP) is traded on Thailand Exchange in Thailand and employs 5 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inter Pharma's market, we take the total number of its shares issued and multiply it by Inter Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Inter Pharma Public classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 372.52 M outstanding shares.
Inter Pharma Public has accumulated about 153.09 M in cash with (41.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53.
Check Inter Pharma Probability Of Bankruptcy
Ownership AllocationInter Pharma Public has a total of 372.52 Million outstanding shares. Inter Pharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Inter Ownership Details
Inter Pharma Public Risk Profiles
Although Inter Pharma's alpha and beta are two of the key measurements used to evaluate Inter Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.78 | |||
| Standard Deviation | 2.92 | |||
| Variance | 8.52 | |||
| Risk Adjusted Performance | (0.03) |
Inter Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Inter Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Inter Pharma Corporate Management
Elected by the shareholders, the Inter Pharma's board of directors comprises two types of representatives: Inter Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inter. The board's role is to monitor Inter Pharma's management team and ensure that shareholders' interests are well served. Inter Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inter Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Trinnawat Thanitnithiphan | CEO Director | Profile | |
| Nattarin Polpuech | CFO Fin | Profile | |
| Napaporn Dechakarat | Director Director | Profile | |
| Chompunuch Meevang | Company Sec | Profile | |
| Apimon Posri | HR Director | Profile |
Other Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.